• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血浆催乳素与结直肠癌中癌胚抗原的相关性

Correlation of Plasma Prolactin and Carcinoembryonic Antigen in Colorectal Cancer.

作者信息

Aseri Parang, Chitara Gayatri, Choudhary Mahendra

机构信息

General Surgery, Dr. Sampurnanand (SN) Medical College, Jodhpur, IND.

Anaesthesiology, Dr. Sampurnanand (SN) Medical College, Jodhpur, IND.

出版信息

Cureus. 2025 Mar 9;17(3):e80285. doi: 10.7759/cureus.80285. eCollection 2025 Mar.

DOI:10.7759/cureus.80285
PMID:40201873
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11977518/
Abstract

Background Carcinoembryonic antigen (CEA) has been widely used as a prognostic marker in colorectal cancer for decades. Elevated levels of prolactin have also been observed in various cancers, including CRC; however, the role of elevated prolactin in colorectal cancer remains unclear. Objective This study aimed to investigate the correlation between plasma prolactin and CEA levels in patients with colorectal cancer. Materials and methods In this observational study, 80 colorectal cancer patients were included. Serum levels of prolactin and CEA were measured using chemiluminescence assay (Siemens AdviaCentaur XP, Siemens Healthineers, Erlangen, Germany). Statistical analysis was performed using the chi-square test, unpaired t-test, and analysis of variance (ANOVA) to evaluate correlations between the two biomarkers. Results Our results showed elevated levels of both plasma prolactin and CEA in colorectal cancer patients. A positive correlation was found between serum prolactin and CEA levels in the patient population. Conclusion The present study found elevated serum prolactin levels in most patients with raised CEA levels. Further research is required to better understand the role of prolactin as a potential prognostic factor in colorectal cancer and to establish the relationship between serum prolactin and CEA.

摘要

背景 几十年来,癌胚抗原(CEA)一直被广泛用作结直肠癌的预后标志物。在包括结直肠癌在内的各种癌症中也观察到催乳素水平升高;然而,催乳素升高在结直肠癌中的作用仍不清楚。目的 本研究旨在探讨结直肠癌患者血浆催乳素与CEA水平之间的相关性。材料和方法 在这项观察性研究中,纳入了80例结直肠癌患者。采用化学发光分析法(德国西门子公司的AdviaCentaur XP,西门子医疗,埃尔朗根)测量催乳素和CEA的血清水平。使用卡方检验、非配对t检验和方差分析(ANOVA)进行统计分析,以评估这两种生物标志物之间的相关性。结果 我们的结果显示,结直肠癌患者的血浆催乳素和CEA水平均升高。在患者群体中,血清催乳素与CEA水平之间存在正相关。结论 本研究发现,大多数CEA水平升高的患者血清催乳素水平也升高。需要进一步研究以更好地了解催乳素作为结直肠癌潜在预后因素的作用,并确定血清催乳素与CEA之间的关系。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcab/11977518/0c112dec2861/cureus-0017-00000080285-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcab/11977518/18d79aba1e18/cureus-0017-00000080285-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcab/11977518/8be3d97853d7/cureus-0017-00000080285-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcab/11977518/3744803b973d/cureus-0017-00000080285-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcab/11977518/0c112dec2861/cureus-0017-00000080285-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcab/11977518/18d79aba1e18/cureus-0017-00000080285-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcab/11977518/8be3d97853d7/cureus-0017-00000080285-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcab/11977518/3744803b973d/cureus-0017-00000080285-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcab/11977518/0c112dec2861/cureus-0017-00000080285-i04.jpg

相似文献

1
Correlation of Plasma Prolactin and Carcinoembryonic Antigen in Colorectal Cancer.血浆催乳素与结直肠癌中癌胚抗原的相关性
Cureus. 2025 Mar 9;17(3):e80285. doi: 10.7759/cureus.80285. eCollection 2025 Mar.
2
Correlation of the Serum Level of Carcinoembryonic Antigen and Prolactin with Different Stages of Colorectal Carcinoma According to Dukes' Staging.根据Dukes分期法探讨血清癌胚抗原和催乳素水平与不同分期结直肠癌的相关性。
Mymensingh Med J. 2016 Jan;25(1):61-5.
3
Plasma prolactin in patients with colorectal cancer. Value in follow-up and as a prognosticator.结直肠癌患者的血浆催乳素。随访价值及作为预后指标的价值。
Cancer. 1994 Feb 1;73(3):570-4. doi: 10.1002/1097-0142(19940201)73:3<570::aid-cncr2820730312>3.0.co;2-i.
4
Plasma prolactin in patients with colorectal cancer.结直肠癌患者的血浆催乳素
BMC Cancer. 2004 Dec 23;4:97. doi: 10.1186/1471-2407-4-97.
5
The Importance of Determining Preoperative Serum Concentration of Carbohydrate Antigen 19-9 and Carcinoembryonic Antigen in Assessing the Progression of Colorectal Cancer.在评估结直肠癌的进展中,确定术前血清糖链抗原 19-9 和癌胚抗原浓度的重要性。
Med Arch. 2020 Oct;74(5):346-349. doi: 10.5455/medarh.2020.74.346-349.
6
Clinical validity of tissue carcinoembryonic antigen expression as ancillary to serum carcinoembryonic antigen concentration in patients curatively resected for colorectal cancer.结直肠癌患者根治性切除术后组织癌胚抗原表达对血清癌胚抗原浓度的辅助临床价值。
Colorectal Dis. 2013 Sep;15(9):e503-11. doi: 10.1111/codi.12304.
7
Comparison of plasma prolactin and CEA in monitoring patients with adenocarcinoma of colon and rectum.血浆催乳素与癌胚抗原在监测结肠直肠癌患者中的比较。
Br J Cancer. 1992 Nov;66(5):977-80. doi: 10.1038/bjc.1992.395.
8
Serum carcinoembryonic antigen to predict recurrence in the follow-up of patients with colorectal cancer.血清癌胚抗原预测结直肠癌患者随访中的复发。
Int J Biol Markers. 2019 Mar;34(1):60-68. doi: 10.1177/1724600818820679. Epub 2019 Mar 11.
9
Prognostic Role of Carcinoembryonic Antigen and Carbohydrate Antigen 19-9 in Stage IV Colorectal Cancer.癌胚抗原和糖类抗原 19-9 在 IV 期结直肠癌中的预后作用。
Anticancer Res. 2022 Aug;42(8):3921-3928. doi: 10.21873/anticanres.15886.
10
The prognostic value of preoperative serum CA724 for CEA-normal colorectal cancer patients.术前血清CA724对癌胚抗原正常的结直肠癌患者的预后价值。
PeerJ. 2020 Apr 14;8:e8936. doi: 10.7717/peerj.8936. eCollection 2020.

本文引用的文献

1
Plasma prolactin in patients with colorectal cancer.结直肠癌患者的血浆催乳素
BMC Cancer. 2004 Dec 23;4:97. doi: 10.1186/1471-2407-4-97.
2
Importance of serum prolactin determination in metastatic breast cancer patients.
Croat Med J. 2004 Apr;45(2):176-80.
3
Effects of prolactin level on burn-induced aberrations in myelopoiesis.催乳素水平对烧伤诱导的骨髓生成异常的影响。
Shock. 2004 Feb;21(2):151-9. doi: 10.1097/01.shk.0000108401.56565.e2.
4
CEA doubling time and CEA half-life in the prediction of recurrences after colorectal cancer surgery.
Jpn J Clin Oncol. 2002 Feb;32(2):41-2. doi: 10.1093/jjco/hyf018.
5
Ectopic production of prolactin by colorectal adenocarcinoma.
Dis Colon Rectum. 2001 Jan;44(1):119-27. doi: 10.1007/BF02234833.
6
Plasma and tissue prolactin detection in colon carcinoma.结肠癌中血浆和组织催乳素的检测
Oncol Rep. 2001 Nov-Dec;8(6):1351-3. doi: 10.3892/or.8.6.1351.
7
Lack of association between hyperprolactinemia and colon carcinoma.高催乳素血症与结肠癌之间不存在关联。
Cancer Invest. 2000;18(2):130-4. doi: 10.3109/07357900009038244.
8
Involvement of prolactin in breast cancer: redefining the molecular targets.催乳素在乳腺癌中的作用:重新定义分子靶点。
Exp Gerontol. 2000 Feb;35(1):41-51. doi: 10.1016/s0531-5565(99)00078-9.
9
Prolactin and colorectal cancer: is there a connection?催乳素与结直肠癌:存在关联吗?
Acta Gastroenterol Belg. 1998 Oct-Dec;61(4):407-9.
10
The effect of benign and malignant liver disease on the tumour markers CA19-9 and CEA.良性和恶性肝脏疾病对肿瘤标志物CA19-9和癌胚抗原(CEA)的影响。
Ann Clin Biochem. 1998 Jan;35 ( Pt 1):99-103. doi: 10.1177/000456329803500113.